CryoLife, Inc. BioGlue Heads to Japan

Atlanta Business Chronicle -- CryoLife Inc.‘s BioGlue Surgical Adhesive will soon be available in Japan. The Kennesaw, Ga.-based implantable biological medical device and cardiovascular tissue processing company got Japanese Ministry of Health, Labor and Welfare approval for the product in fall 2010 and will make it available starting in May. It estimates the annual Japanese market for the use of surgical adhesives in the repair of aortic dissection is $10 million and the total annual market for the use of adhesives and sealants in Japan is $150 million.